Rani Therapeutics Holdings Inc’s recent filing unveils that its Chief Executive Officer Imran Talat acquired Company’s shares for reported $22700.0 on Dec 06 ’23. In the deal valued at $2.27 per share,10,000 shares were bought. As a result of this transaction, Imran Talat now holds 484,455 shares worth roughly $3.33 million.
Then, Imran Talat bought 5,000 shares, generating $12,850 in total proceeds. Upon buying the shares at $2.57, the Chief Executive Officer now owns 474,455 shares.
Before that, Imran Talat bought 20,000 shares. Rani Therapeutics Holdings Inc shares valued at $41,000 were divested by the Chief Executive Officer at a price of $2.05 per share. As a result of the transaction, Imran Talat now holds 469,455 shares, worth roughly $3.23 million.
A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in mid October with a ‘”a Buy”‘ rating. H.C. Wainwright began covering RANI with “Buy” recommendation on July 27, 2022. Wedbush started covering the stock on June 13, 2022. It rated RANI as “an Outperform”.
Price Performance Review of RANI
On Tuesday, Rani Therapeutics Holdings Inc [NASDAQ:RANI] saw its stock jump 19.27% to $6.87. Over the last five days, the stock has gained 71.75%. Rani Therapeutics Holdings Inc shares have risen nearly 106.93% since the year began. Nevertheless, the stocks have risen 31.11% over the past one year. While a 52-week high of $5.80 was reached on 04/16/24, a 52-week low of $1.82 was recorded on 01/08/24. SMA at 50 days reached $3.66, while 200 days put it at $3.26. A total of 0.37 million shares were traded, compared to the trading of 0.22 million shares in the previous session.
Levels Of Support And Resistance For RANI Stock
The 24-hour chart illustrates a support level at 6.12, which if violated will result in even more drops to 5.36. On the upside, there is a resistance level at 7.26. A further resistance level may holdings at 7.64. The Relative Strength Index (RSI) on the 14-day chart is 88.71, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.90, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 0.51%. Stochastics %K at 96.26% indicates the stock is a selling.
